(Q34488936)

2 August 2017

Long term treatment of acromegaly with a long acting analogue of somatostatin (English)

1 reference

2 August 2017

Ch'ng LJ

1

1 reference

2 August 2017

Sandler LM

2

1 reference

2 August 2017

Kraenzlin ME

3

1 reference

2 August 2017

Burrin JM

4

1 reference

2 August 2017

Joplin GF

5

1 reference

2 August 2017

Bloom SR

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 1985

1 reference

2 August 2017

1 reference

2 August 2017

290

1 reference

2 August 2017

6464

1 reference

2 August 2017

284-285

1 reference

Conventional pituitary irradiation in acromegaly. Effect on growth hormone and TSH secretion

2 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417552

Growth Hormone Hypersecretion and Acromegaly

6 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417552

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

6 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1417552

Acromegaly and cardiovascular disorders. A prospective study

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2857104

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Growth hormone release inhibiting hormone in acromegaly

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2857104

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.290.6464.284-A

0 references

PMCID

1417552

1 reference

2 August 2017

1 reference